Scarica l'app Stockscreener
0.5456
9.12%
0.0456
Precedente Chiudi:
$0.50
Aprire:
$0.4927
Volume 24 ore:
3.26M
Relative Volume:
0.97
Capitalizzazione di mercato:
$12.20M
Reddito:
-
Utile/perdita netta:
$-22.79M
Rapporto P/E:
-0.3242
EPS:
-1.6827
Flusso di cassa netto:
$-12.07M
1 W Prestazione:
+40.87%
1M Prestazione:
-48.53%
6M Prestazione:
-77.36%
1 anno Prestazione:
-84.14%
Intervallo 1D:
$0.4835
$0.5792
Intervallo di 1 settimana:
$0.3864
$0.7229
Portata 52W:
$0.37
$8.94
Medicus Pharma Ltd Stock (MDCX) Company Profile
Nome
Medicus Pharma Ltd
Settore
Industria
Telefono
610-540-7515
Indirizzo
300 CONSHOHOCKEN STATE RD., W. CONSHOHOCKEN
Compare MDCX vs LLY, JNJ, ABBV, AZN, NVS
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MDCX
Medicus Pharma Ltd
|
0.5456 | 12.20M | 0 | -22.79M | -12.07M | -1.6827 |
|
LLY
Lilly Eli Co
|
985.08 | 879.67B | 65.18B | 20.64B | 5.96B | 22.59 |
|
JNJ
Johnson Johnson
|
241.52 | 582.04B | 94.19B | 26.80B | 19.70B | 11.05 |
|
ABBV
Abbvie Inc
|
219.68 | 388.43B | 61.16B | 4.19B | 17.82B | 2.3614 |
|
AZN
Astrazeneca Plc
|
189.90 | 294.50B | 58.80B | 10.24B | 8.98B | 3.2788 |
|
NVS
Novartis Ag Adr
|
153.44 | 292.79B | 54.72B | 14.02B | 15.32B | 7.1855 |
Medicus Pharma Ltd Borsa (MDCX) Ultime notizie
Medicus Pharma CEO discusses promising Phase 2 SkinJect resultsICYMI - Proactive financial news
Medicus Pharma on Bloomberg World - The Journal News | lohud.com
Medicus Pharma Marks Nasdaq Anniversary with Opening Bell Ceremony - The Globe and Mail
Risk Report: Will Medicus Pharma Ltd outperform the market in YEAR2026 Update & High Accuracy Investment Signals - baoquankhu1.vn
Medicus Pharma receives FDA clearance to begin Phase 2b Teverelix study - MSN
Medicus Pharma reports phase 2 results for basal cell carcinoma therapy - MSN
Medicus Pharma Reports Phase 2 Results for Basal Cell Carcinoma Therapy - MyChesCo
Medicus Pharma to spotlight AI-driven drug development at Longwood Miami CEO Forum - Proactive financial news
Medicus Pharma to Showcase AI-Enabled Drug Development at Longwood Miami CEO Forum - National Today
Medicus Pharma to Spotlight AI-Driven Drug Development at Longwood Miami CEO Forum - TipRanks
Medicus Pharma Ltd. To Participate In The Longwood Miami CEO Forum - Weatherford Democrat
Medicus Pharma to Present Drug Development Programs at Roth Conference - MyChesCo
Medicus Pharma prices $7 million share offering - MSN
MDCX Maintains Buy Rating with Stable Price Target | MDCX Stock News - GuruFocus
Small cap wrap: Medicus Pharma, C3 Metals, Protalix BioTherapeutics… - Proactive financial news
Medicus Pharma provides additional Phase 2 data for SkinJect Cancer therapy - Proactive financial news
Medicus Pharma Highlights Strong Phase 2 SkinJect Results in Basal Cell Carcinoma - TipRanks
Medicus says Phase 2 data supports further development of SkinJect therapy for skin cancer - Proactive financial news
Medicus Pharma Provides Interpretation of Positive Phase 2 SkinJect™ Dataset - The Manila Times
Aug Ideas: Can Medicus Pharma Ltd Equity Warrant disrupt its industryWeekly Market Outlook & Free Accurate Trade Setup Notifications - baoquankhu1.vn
Medicus Pharma Raises Equity Financing, Reduces Yorkville Debenture - The Globe and Mail
Medicus Pharma CEO discusses Phase 2 skin cancer resultsICYMI - Proactive financial news
Medicus Pharma Reports Phase 2 Results for Skin Cancer Patch - MyChesCo
Medicus Pharma (MDCX) registers 1.12M shares; Yorkville bought 4.47M shares - Stock Titan
Medicus Pharma (MDCX) sells 4.47M shares to Yorkville and prepays part of debenture - Stock Titan
Aug Intraday: Is Medicus Pharma Ltd Equity Warrant subject to activist investor interestWeekly Profit Recap & Low Drawdown Trading Techniques - baoquankhu1.vn
Medicus Pharma Reports Positive Phase 2 SKNJCT-003 Topline Data Observing 73% Clinical Clearance and 40% Histological Clearance (CR) at Day 57 in 200μg Cohort - Sahm
Medicus Pharma Marks Nasdaq Anniversary With Opening Bell Ceremony - Southwest Times Record
Small caps: Medicus Pharma, BioHarvest Sciences, Bit Digital, Nextech3D.ai… - Proactive financial news
Small cap wrap: Medicus Pharma, BioHarvest Sciences, Bit Digital, Nextech3D.ai… - Proactive Investors
Medicus Pharma Ltd Reports Positive Phase 2 SKNJCT-003 Topline Data Observing 73% Clinical Clearance And 40% Histological Clearance (CR) At Day 57 In 200µg Cohort - marketscreener.com
Medicus Pharma reports positive phase 2 results for microneedle skin cancer treatment - Proactive financial news
MDCX Navigates Uncertain Waters Amid Recent Earnings and Market Trends - timothysykes.com
Medicus Pharma Stock Swings After Skin Cancer Treatment Results - Benzinga
Medicus Pharma reports positive Phase 2 results for microneedle treatment for basal cell carcinoma - Yahoo Finance
Medicus Pharma Posts Strong Phase 2 Data for Microneedle Basal Cell Carcinoma Therapy - TipRanks
Microneedle skin cancer patch shows 73% clearance in Medicus trial - Stock Titan
New to The Street to Broadcast Executive Leadership Interviews Featuring Medicus Pharma Ltd. (NASDAQ:MDCX), CitroTech (NYSE:CITR), Vivos Therapeutics, Inc. (NASDAQ:VVOS), and Virtuix Holdings ($VTIX) on Bloomberg Television Tonight at 6:30 PM - ACCESS Newswire
MDCXMedicus Pharma on Bloomberg World - mx.advfn.com
Medicus Pharma Showcases SkinJect and Teverelix Strategy at Roth Conference - TipRanks
Medicus Pharma to present at Roth Conference - Proactive financial news
Medicus Pharma Ltd Azioni (MDCX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):